Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment

The treatment of glioblastoma has limited clinical progress over the past decade, partly due to the lack of effective drug delivery strategies across the blood-brain-tumor barrier. Moreover, discrepancies between preclinical and clinical outcomes demand a reliable translational platform that can pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Qi, Li, Xiaoqing, Xiong, Hejian, Fan, Hanwen, Gao, Xiaofei, Vemireddy, Vamsidhara, Margolis, Ryan, Li, Junjie, Ge, Xiaoqian, Giannotta, Monica, Hoyt, Kenneth, Maher, Elizabeth, Bachoo, Robert, Qin, Zhenpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427669/
https://www.ncbi.nlm.nih.gov/pubmed/37582846
http://dx.doi.org/10.1038/s41467-023-40579-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427669/
https://www.ncbi.nlm.nih.gov/pubmed/37582846
http://dx.doi.org/10.1038/s41467-023-40579-1

Ejemplares similares